| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Clarus Therapeutics Holdings, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 72,500 | 11 Dec 2021 | Direct | ||
| Clarus Therapeutics Holdings, Inc. | Chief Commercial Officer | Common Stock | 29,000 | 11 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRXT | Clarus Therapeutics Holdings, Inc. | 11 Dec 2021 | 2 | $0 | 4 | Chief Commercial Officer | 14 Dec 2021, 18:02 |
| CRXT | Clarus Therapeutics Holdings, Inc. | 09 Sep 2021 | 0 | $0 | 3 | Chief Commercial Officer | 13 Sep 2021, 20:38 |